MRI鉴别胰腺神经内分泌肿瘤G3与癌G3的价值
回顾性纳入2009至2019年中国两家医院31例术前行MRI的pNEN-G3切除患者,分为pNET-G3组13例与pNEC-G3组18例并比较MRI表现。两组病变大小、临床及实验室指标无显著差异;DWI均呈高或稍高信号且ADC值降低,但ADC值组间差异有统计学意义(p=0.013)。正向强化积分、动脉期及门脉期信号强化率组间差异有统计学意义,延迟期信号强化率无显著差异。结论提示ADC值与动态增强成像有助于区分pNET-G3与pNEC-G3。
要点
- ADC值在pNET-G3与pNEC-G3间差异有统计学意义(p=0.013),可辅助鉴别。
- 动脉期及门脉期信号强化率、正向强化积分组间有显著差异,延迟期强化率无差异。
- 病变大小、临床特征及实验室指标在两组间无统计学显著差异,鉴别价值有限。
核心结论
- pNET-G3与pNEC-G3在MRI上表现不同,ADC值和动态增强成像在两者鉴别中可能起重要作用。
研究设计与样本
- 回顾性研究,2009至2019年中国两家医院共31例经切除的pNEN-G3患者,术前均行MRI。
- 按病理分为pNET-G3组13例与pNEC-G3组18例,比较两组MRI表现。
关键影像表现/征象
- 两组病变在DWI上均呈高或稍高信号,ADC值降低,但ADC值在两组间差异有统计学意义(p=0.013)。
- 正向强化积分、动脉期及门脉期信号强化率在两组间差异有统计学意义。
- 延迟期信号强化率在两组间无显著差异。
- 病变大小、临床特征及实验室指标在两组间无统计学显著差异。
诊断标准与关键数值
- ADC值组间比较p=0.013,提示ADC值可用于区分pNET-G3与pNEC-G3。
- 正向强化积分、动脉期及门脉期信号强化率组间差异有统计学意义,延迟期信号强化率无显著差异。
临床应用与阅片要点
- 阅片时应关注DWI信号及ADC值,并结合动态增强动脉期、门脉期强化率辅助鉴别pNET-G3与pNEC-G3。
- 延迟期强化率在两组间无显著差异,不宜单独作为鉴别依据。
局限性
- 回顾性研究,样本量较小(共31例),仅来自两家医院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To explore the magnetic resonance imaging (MRI) differences between pancreatic neuroendocrine tumour grade 3 (pNET-G3) and pancreatic neuroendocrine carcinoma grade 3 (pNEC-G3).
MATERIALS AND METHODS: Between 2009 and 2019, 31 patients underwent pNEN-G3 resection with preoperative MRI in two local hospitals in China. The 31 patients were assigned to a pNET-G3 group (n=13) or a pNEC-G3 group (n=18). The MRI findings between the groups were compared.
RESULTS: There was no statistically significant difference between the two groups in lesion size, clinical characteristics, or laboratory indexes. The lesions showed high or slightly higher signal on diffusion-weighted imaging and decreased apparent diffusion coefficient (ADC) values, which differed between the two groups (p=0.013). The difference between the groups regarding positive enhancement integral, arterial phase and portal phase signal enhancement ratio were statistically significant; however, the delayed phase signal enhancement ratio was not significantly different.
CONCLUSIONS: pNET-G3 and pNEC-G3 showed different characteristics on MRI. In particular, the ADC value and dynamic enhanced imaging could have an important role in distinguishing between the two.
引用
- Xu W, Zhang H, Feng G, et al. The value of MRI in identifying pancreatic neuroendocrine tumour G3 and carcinoma G3. Clin Radiol. 2021. PMID: 33902887. doi:10.1016/j.crad.2021.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。